Guggenheim named Madison Square Garden Sports Corp (NYSE:MSGS) its "best idea" for 2025 given strong secular growth in live ...

There’s some surprising Jewish history to be found at this annual attraction, where model trains traverse a mini New York ...

First Stamford Place is the new home of Guggenheim Partners' Connecticut office. Photo courtesy of Newmark Group STAMFORD – The ...

Guggenheim says AI driven increase in power demand is in its early innings. Its analyst recommends owning CEG, Vistra Corp, ...

From Renaissance masterpieces to mammoth-inspired landscapes, these shows promise unforgettable artistic experiences.

Analysts at Guggenheim have initiated Reddit (NYSE:RDDT) with a "buy" rating on Friday. They believe the company is poised to ...

The Guggenheim's Orphism exhibition includes more than 90 artworks on display in its iconic rotunda, celebrating the 1910s ...

Cryoport (CYRX), and Sartorius (SARTF) stocks win buy from Guggenheim while Maravai LifeSciences (MRVI) was granted a neutral rating. Read more here.

Guggenheim analyst Subbu Nambi initiated coverage of Bruker (BRKR) with a Buy rating and $72 price target The “best-in-class,” largely ...

Guggenheim analyst Subbu Nambi initiated coverage of Danaher (DHR) with a Buy rating and $275 price target as the firm expands its ...

On Monday, Guggenheim reaffirmed a Buy rating and a $26.00 price target for Larimar Therapeutics (NASDAQ:LRMR) following the company's presentation of encouraging clinical trial data. With the stock ...

On Monday, Guggenheim reaffirmed a Buy rating and a $26.00 price target for Larimar Therapeutics (NASDAQ:LRMR) following the company's presentation of encouraging clinical trial data. With the ...